“Anthony Fauci’s National Institutes of Health agency was funding research to identify treatments for monkeypox shortly before the virus began spreading in a global outbreak,” The National Pulse reports.
BREAKING: Fauci’s NIH agency was funding research to identify treatments for monkeypox shortly before the virus began spreading in a global outbreak. pic.twitter.com/hylkdhn6e7
— Te𝕏asLindsay™ (@TexasLindsay_) May 30, 2022
Seems convenient that Fauci was funding research into monkeypox cures shortly before an outbreak started.https://t.co/QnjeQKj2CB
— Natalie Winters (@nataliegwinters) May 30, 2022
Fauci’s agency, the National Institute of Allergy and Infectious Diseases (NIAID), has faced scrutiny for funding bat coronavirus research at the Wuhan Institute of Virology.
Many public health experts and intelligence officials believe the Fauci-funded research to be the source of COVID-19.
Now, the NIAID has raised suspicions for researching potential monkeypox cures shortly before the viral disease began spreading in a global outbreak.
From The National Pulse:
The grant supports a “randomized, placebo-controlled trial of the safety and efficacy of tecovirimat for the treatment of patients with monkeypox virus disease.”
“The funding supports a clinical trial to identify effective treatments for monkeypox virus disease,” explains a summary of the research, which, despite beginning in September 2020, has not generated any publicly available studies, papers, or patents.
“The similarity between monkeypox and the variola virus, coupled with concerns about the potential of the variola virus as a potential bioterrorism agent, have placed monkeypox treatments at the forefront of public health and scientific research agendas in many countries,” adds the grant summary.
The National Institutes of Health (NIH) grant database shows that $9,824,009 was sent to Leidos Biomedical Research, which partners with the NIH’s National Cancer Institute (NCI) to operate Frederick National Laboratory for Cancer Research, in 2021.
The grant, which is set to conclude on September 27th, 2025, was distributed to Lori Dodd, who serves as a Mathematical Statistician in the Biostatistics Research Branch of the NIAID.
Dodd was previously exposed for her involvement in the NIAID’s efforts to cover up the agency reportedly altering the endpoint in a trial testing the effects of remdesivir against COVID-19 to make it look more effective.
*Source*
Fraudci also awarded $100 million to Bavarian Nordic A/S to research a smallpox vaccine.
The Biden Administration ordered $119 million worth of the vaccine from Bavarian Nordic and Biden sets to profit off the order.
Biden Admin Orders $119 Million Worth of Monkeypox Vaccines
Here’s How Biden Sets to Profit Off the Monkeypox Vaccine He Ordered
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!